Miao Ziping, Du Yuxia, Dai Anqi, Yang Mengya, Chen Can, Yan Rui, Gao Jian, Chen Yijuan, Cao Kexin, Jiang Daixi, Zhang Xiaobao, Wu Xiaoyue, Chen Mengsha, You Yue, Zhou Wenkai, Chen Dingmo, Qi Jiaxing, Zhao Shiyong, Lin Xianyao, Yang Shigui
Department of Communicable Diseases Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Department of Epidemiology and Biostatistics, School of Public Health, Department of Emergency Medicine, Second Affiliated Hospital, The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, China.
Front Public Health. 2025 May 9;13:1596899. doi: 10.3389/fpubh.2025.1596899. eCollection 2025.
Rotavirus infection, the most common cause of infant infectious diarrhoea and related deaths worldwide, has imposed a high disease burden in China, especially in Zhejiang Province. This study described the overall epidemiological characteristics and trends of reported rotavirus infections in Zhejiang Province from 2005 to 2022 and evaluated the effectiveness of rotavirus vaccines on the incidence of rotavirus infection.
Data on reported cases of rotavirus infection from 2005 to 2022 were extracted from the China Disease Prevention and Control Information System. Information on rotavirus vaccination was obtained from the Zhejiang Provincial Viral Diarrhoea Surveillance Site in 2022. Join-point regression, spatial and temporal aggregation analysis, and an age-period-cohort model were used to explore the epidemiological trends of rotavirus infection. Interrupted time series analysis and an overdispersed Poisson model were used to quantify the effectiveness of rotavirus vaccines.
The average age-standardized reporting incidence rate (ASRIR) of rotavirus infection in Zhejiang Province was 38.58/100,000, particularly in children aged 0-2 years, who had the highest average annual incidence of 951.63/100,000. The annual ASRIR of all ages showed a significant upward trend before 2017 (average percentage change [APC] = 21.64%) and then decreased significantly (APC = -23.02%). However, in children aged 6-19 years, the annual incidence presented a sustained and significant upward trend over time. The rotavirus infection peak showed a seasonal drift in Zhejiang Province, shifting from November before 2014 to January after 2014. Spatiotemporal aggregation revealed two clusters. The spatio-temporal scanning found two spatio-temporal aggregation areas, the first level spatio-temporal aggregation area was distributed in Hangzhou, Jiaxing and Huzhou, and the second level spatio-temporal aggregation area was Lishui. The age-period-cohort model indicated that the risk of rotavirus infection was primarily concentrated in children aged 0-4 years. The vaccine effectiveness (VE) of rotavirus vaccines was 71.62% (95% confidence interval [CI]: 45.21-86.05%) in children aged 2-59 months, in which the VE of the human-bovine reassortant pentavalent vaccine (RV5) was 91.31% (95% CI: 74.39-97.97%). Since the implementation of RV5 vaccination in September 2018, the number of cases of rotavirus infection per month has decreased by 3,061 (65.27%) in Zhejiang Province.
The disease burden of rotavirus infection in Zhejiang Province was high, especially in children. Rotavirus vaccination have significantly reduced the incidence rate of rotavirus infection. Therefore, the prevention of infectious diarrhoea should be further strengthened, especially through increased coverage with the rotavirus vaccine.
轮状病毒感染是全球婴幼儿感染性腹泻及相关死亡的最常见原因,在中国造成了较高的疾病负担,尤其是在浙江省。本研究描述了2005年至2022年浙江省报告的轮状病毒感染的总体流行病学特征和趋势,并评估了轮状病毒疫苗对轮状病毒感染发病率的有效性。
从中国疾病预防控制信息系统中提取2005年至2022年报告的轮状病毒感染病例数据。2022年从浙江省病毒性腹泻监测点获取轮状病毒疫苗接种信息。采用连接点回归、时空聚集分析和年龄-时期-队列模型探讨轮状病毒感染的流行病学趋势。采用中断时间序列分析和过度分散泊松模型量化轮状病毒疫苗的有效性。
浙江省轮状病毒感染的平均年龄标准化报告发病率(ASRIR)为38.58/10万,特别是0至2岁儿童,其年均发病率最高,为951.63/10万。各年龄段的年度ASRIR在2017年前呈显著上升趋势(平均变化百分比[APC]=21.64%),随后显著下降(APC=-23.02%)。然而,6至19岁儿童的年发病率随时间呈持续显著上升趋势。浙江省轮状病毒感染高峰呈现季节性漂移,从2014年前的11月转移至2014年后的1月。时空聚集显示有两个聚集区。时空扫描发现两个时空聚集区域,一级时空聚集区域分布在杭州、嘉兴和湖州,二级时空聚集区域为丽水。年龄-时期-队列模型表明,轮状病毒感染风险主要集中在0至4岁儿童。2至59月龄儿童轮状病毒疫苗的疫苗效力(VE)为71.62%(95%置信区间[CI]:45.21-86.05%),其中人-牛重配五价疫苗(RV5)的VE为91.31%(95%CI:74.39-97.97%)。自2018年9月实施RV5疫苗接种以来,浙江省每月轮状病毒感染病例数减少了3061例(65.27%)。
浙江省轮状病毒感染的疾病负担较高,尤其是儿童。轮状病毒疫苗接种显著降低了轮状病毒感染的发病率。因此,应进一步加强感染性腹泻的预防,特别是通过提高轮状病毒疫苗的接种覆盖率。